These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 12595155)
1. Binding of nitrobenzene to hepatic DNA and hemoglobin at low doses in mice. Li H; Wang H; Sun H; Liu Y; Liu K; Peng S Toxicol Lett; 2003 Mar; 139(1):25-32. PubMed ID: 12595155 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of nitrobenzene-induced DNA and hemoglobin adductions by dietary constituents. Li H; Cheng Y; Wang H; Sun H; Liu Y; Liu K; Peng S Appl Radiat Isot; 2003 Mar; 58(3):291-8. PubMed ID: 12595006 [TBL] [Abstract][Full Text] [Related]
3. Dose-dependent binding of trichloroethylene to hepatic DNA and protein at low doses in mice. Kautiainen A; Vogel JS; Turteltaub KW Chem Biol Interact; 1997 Sep; 106(2):109-21. PubMed ID: 9366897 [TBL] [Abstract][Full Text] [Related]
4. Nitrobenzene carcinogenicity in animals and human hazard evaluation. Holder JW Toxicol Ind Health; 1999 Aug; 15(5):445-57. PubMed ID: 10487355 [TBL] [Abstract][Full Text] [Related]
5. Formation of MTBE-DNA adducts in mice measured with accelerator mass spectrometry. Du HF; Xu LH; Wang HF; Liu YF; Tang XY; Liu KX; Peng SX Environ Toxicol; 2005 Aug; 20(4):397-401. PubMed ID: 16007660 [TBL] [Abstract][Full Text] [Related]
6. Dose-response studies of MeIQx in rat liver and liver DNA at low doses. Frantz CE; Bangerter C; Fultz E; Mayer KM; Vogel JS; Turteltaub KW Carcinogenesis; 1995 Feb; 16(2):367-73. PubMed ID: 7859370 [TBL] [Abstract][Full Text] [Related]
7. MeIQx-DNA adduct formation in rodent and human tissues at low doses. Turteltaub KW; Mauthe RJ; Dingley KH; Vogel JS; Frantz CE; Garner RC; Shen N Mutat Res; 1997 May; 376(1-2):243-52. PubMed ID: 9202761 [TBL] [Abstract][Full Text] [Related]
8. Tissue distribution and macromolecular binding of extremely low doses of [14C]-benzene in B6C3F1 mice. Creek MR; Mani C; Vogel JS; Turteltaub KW Carcinogenesis; 1997 Dec; 18(12):2421-7. PubMed ID: 9450490 [TBL] [Abstract][Full Text] [Related]
9. Adduction of biomacromolecules with acrylamide (AA) in mice at environmental dose levels studied by accelerator mass spectrometry. Xie Q; Sun H; Liu Y; Ding X; Fu D; Liu K Toxicol Lett; 2006 May; 163(2):101-8. PubMed ID: 16280212 [TBL] [Abstract][Full Text] [Related]
10. Dosimetry by means of DNA and hemoglobin adducts in propylene oxide-exposed rats. Osterman-Golkar S; Czene K; Lee MS; Faller TH; Csanády GA; Kessler W; Pérez HL; Filser JG; Segerbäck D Toxicol Appl Pharmacol; 2003 Sep; 191(3):245-54. PubMed ID: 13678657 [TBL] [Abstract][Full Text] [Related]
11. Nitrobenzene potential human cancer risk based on animal studies. Holder JW Toxicol Ind Health; 1999 Aug; 15(5):458-63. PubMed ID: 10487356 [TBL] [Abstract][Full Text] [Related]
12. Relationships between biomarkers of exposure and toxicokinetics in Fischer 344 rats and B6C3F1 mice administered single doses of acrylamide and glycidamide and multiple doses of acrylamide. Tareke E; Twaddle NC; McDaniel LP; Churchwell MI; Young JF; Doerge DR Toxicol Appl Pharmacol; 2006 Nov; 217(1):63-75. PubMed ID: 17007897 [TBL] [Abstract][Full Text] [Related]
13. The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposure. Cupid BC; Lightfoot TJ; Russell D; Gant SJ; Turner PC; Dingley KH; Curtis KD; Leveson SH; Turteltaub KW; Garner RC Food Chem Toxicol; 2004 Apr; 42(4):559-69. PubMed ID: 15019179 [TBL] [Abstract][Full Text] [Related]
14. Comparison of in vivo binding of aromatic nitro and amino compounds to rat hemoglobin. Suzuki J; Meguro S; Morita O; Hirayama S; Suzuki S Biochem Pharmacol; 1989 Oct; 38(20):3511-9. PubMed ID: 2818643 [TBL] [Abstract][Full Text] [Related]
15. Biomonitoring of aniline and nitrobenzene. Hemoglobin binding in rats and analysis of adducts. Albrecht W; Neumann HG Arch Toxicol; 1985 Apr; 57(1):1-5. PubMed ID: 4015392 [TBL] [Abstract][Full Text] [Related]
16. Hemoglobin adducts and micronucleus frequencies in mouse and rat after acrylamide or N-methylolacrylamide treatment. Paulsson B; Grawé J; Törnqvist M Mutat Res; 2002 Apr; 516(1-2):101-11. PubMed ID: 11943616 [TBL] [Abstract][Full Text] [Related]
17. Hemoglobin and DNA adducts in rats exposed to 2-nitrotoluene. Jones CR; Beyerbach A; Seffner W; Sabbioni G Carcinogenesis; 2003 Apr; 24(4):779-87. PubMed ID: 12727807 [TBL] [Abstract][Full Text] [Related]
18. Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA. Turteltaub KW; Felton JS; Gledhill BL; Vogel JS; Southon JR; Caffee MW; Finkel RC; Nelson DE; Proctor ID; Davis JC Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5288-92. PubMed ID: 2371271 [TBL] [Abstract][Full Text] [Related]
19. Covalent binding of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline to albumin and hemoglobin at environmentally relevant doses. Comparison of human subjects and F344 rats. Dingley KH; Freeman SP; Nelson DO; Garner RC; Turteltaub KW Drug Metab Dispos; 1998 Aug; 26(8):825-8. PubMed ID: 9698300 [TBL] [Abstract][Full Text] [Related]
20. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]